Description: The Gained in Translation Symposium is a meeting of clinicians and vision scientists from University of Washington, University of British Columbia, and Oregon Health Sciences University. Presentations focus on bridging the gap between disease treatment and the latest advances in translational and basic research. Areas of synergy are identified for future collaboration between these institutions. Clinical and research faculty, community colleagues, residents, fellows, and students are welcome to attend. Trainees and students are encouraged to present posters.
Date: Saturday, November 12, 2022
Time: 7:30 am to 5:00 pm
Agenda: available here
Registration: available here
Meeting Organizers: Matthew Zhang, MD (UW), Ethan Buhr, PhD (UW), Shandiz Therani, MD, PhD (OHSU), Claire Sheldon, MD, PhD (UBC), Kaivon Pakzad-Vaezi, MD
The University of Washington School of Medicine designates this live activity for a maximum of5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
1. Analyze the clinical challenges in the treatment of myopia
2. Explain the key drivers for the development of myopia
3. Implement novel treatments of myopia and of ROP
4. Cite the neurological cause of Prosopagnosia
5. Examine machine learning and how it can improve clinical care in patients with Prosopagnosia
6. Recognize new molecular drivers in the pathogenesis of retinal degeneration
Planning Committee Disclosures:
Program Chair Dr. Matthew Zhang, MD, has no relevant commercial interests to disclose. Program Co-Chair Dr. Ethan Buhr, PhD, has no relevant commercial interests to disclose. Committee member Dr. Shandiz Therani, MD, PhD, has no relevant commercial interests to disclose. Committee member Dr. Shandiz Tehrani MD, PhD, has no relevant commercial interests to disclose. Committee member Dr. Claire Sheldon MD, PhD, has no relevant commercial interests to disclose. Committee member Kaivon Pakzad-Vaezi has no relevant commercia interests to disclose.